Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skippingPeter Gee, Akitsu Hotta|Nature Communications|2020Cited by 359
Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in miceEriya Kenjo, Akitsu Hotta|Nature Communications|2021Cited by 277
Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA RibonucleoproteinAkihiro Kagita, Akitsu Hotta|Stem Cell Reports|2021Cited by 51
Beneath the radar: immune-evasive cell sources for stroke therapyBeatriz Achón Buil, Ruslan Rust, R. Weber et al.|Trends in Molecular Medicine|2024Cited by 18